Suppr超能文献

尽管使用α干扰素治疗, Erdheim-Chester病仍迅速进展为心脏压塞。

Rapid progression to cardiac tamponade in Erdheim-Chester disease despite treatment with interferon alpha.

作者信息

Nakhleh Afif, Slobodin Gleb, Elias Nizar, Bejar Jacob, Odeh Majed

机构信息

a Department of Internal Medicine A , Bnai Zion Medical Center, Faculty of Medicine , Technion , Haifa , Israel.

b Department of Pathology , Bnai Zion Medical Center, Faculty of Medicine , Technion , Haifa , Israel.

出版信息

Mod Rheumatol. 2016 Jul;26(4):621-4. doi: 10.3109/14397595.2014.905235. Epub 2014 Apr 23.

Abstract

Erdheim-Chester disease (ECD) is a rare form of non-Langerhans histiocytosis with heterogeneous clinical manifestations. The most common presentation is bone pains typically involving the long bones. Approximately 75% of the patients develop extraskeletal involvement. Cardiac involvement is seen in up to 45% of the patients, and although, pericardial involvement is the most common cardiac pathology of this rare disease, cardiac tamponade due to ECD has been very rarely reported. We describe a case of a patient found to have ECD with multi-organ involvement and small pericardial effusion, which progressed to cardiac tamponade despite treatment with interferon alpha.

摘要

厄尔德海姆-切斯特病(ECD)是一种罕见的非朗格汉斯组织细胞增多症,临床表现多样。最常见的表现是骨痛,通常累及长骨。约75%的患者会出现骨骼外受累。高达45%的患者会出现心脏受累,虽然心包受累是这种罕见疾病最常见的心脏病理表现,但由ECD导致的心包填塞却鲜有报道。我们描述了一例被诊断为ECD且多器官受累并伴有少量心包积液的患者,尽管接受了干扰素α治疗,仍进展为心包填塞。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验